NCT01831609招募中不适用
Biomarker Analysis of Solid Cancers Such as Gastrointestinal Cancer
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 1,000
- 试验地点
- 1
- 主要终点
- Biomarker analyses to predict treatment response in metastatic cancer
研究概览
简要总结
To prospectively collect ascites, pleural fluid, circulating tumor cells and derived primary cultures from metastatic cancer patients. The specimens will be analyzed using DNA/RNA/proteomic approaches.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with histologically confirmed gastrointestinal, genitourinary, sarcoma, rare cancer
- •Written informed consent
- •body fluid derived from cancer, available for drainage and collection
排除标准
- •patients who do not give informed consent form for research use of biomaterials/biospecimens
结局指标
主要结局
Biomarker analyses to predict treatment response in metastatic cancer
时间窗: 3 year
Using patient derived tumor cells, predictive biomarker analyses (DNA, RNA protein levels etc) will be assessed.
次要结局
未报告次要终点
研究者
Jeeyun Lee
Assistant Professor
Samsung Medical Center
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Study of Tissue and Blood Samples From Patients With High-Grade GliomaBrain and Central Nervous System TumorsNCT01004887Alliance for Clinical Trials in Oncology631
招募中
不适用
Acquisition of Blood and Tumor Tissue Samples From Patients With Gastrointestinal CancerNon-GI CancersCancer of Gastrointestinal TractGastrointestinal CancerNCT01313442National Cancer Institute (NCI)550
招募中
不适用
Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer PatientsPrecancerous ConditionColorectal CancerPancreatic CancerGastric CancerEsophageal CancerNCT00899626Vanderbilt University Medical Center5,000
招募中
不适用
Characterization of Tissue Biochemical Composition in Gastric Precancerous/Cancerous LesionsGastric CancerNCT05977478National University Hospital, Singapore25
招募中
不适用
Biomarkers and Molecular Mechanism Study of Hepatocellular Carcinoma After Radical Resection and Conversion TherapyHepatocellular CarcinomaNCT06382103Shanghai Zhongshan Hospital240